HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia L Cruz Selected Research

ICI 204448

11/2007Subcutaneous, intrathecal and periaqueductal grey administration of asimadoline and ICI-204448 reduces tactile allodynia in the rat.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvia L Cruz Research Topics

Disease

4Hyperalgesia
04/2022 - 11/2007
3Pain (Aches)
04/2022 - 04/2009
3Cognitive Dysfunction
05/2019 - 07/2012
2Neuroinflammatory Diseases
04/2022 - 01/2020
2Hallucinations (Hallucination)
10/2015 - 01/2011
1Leukopenia
01/2022
1Neutropenia
01/2022
1Necrosis
12/2021
1Opiate Overdose
12/2021
1Seizures (Absence Seizure)
12/2016
1Body Weight (Weight, Body)
11/2013
1Neuralgia (Stump Neuralgia)
04/2009
1Inhalant Abuse
11/2006
1Cardiac Arrhythmias (Arrythmia)
10/2003

Drug/Important Bio-Agent (IBA)

7TolueneIBA
01/2020 - 10/2003
4Morphine (MS Contin)FDA LinkGeneric
04/2022 - 10/2009
4N-Methylaspartate (NMDA)IBA
05/2019 - 11/2006
4SolventsIBA
12/2016 - 10/2003
3Opioid Receptors (Opioid Receptor)IBA
04/2022 - 04/2009
2Minocycline (Cyclops)FDA LinkGeneric
04/2022 - 01/2020
2Fentanyl (Sublimaze)FDA LinkGeneric
04/2022 - 12/2021
2Anticonvulsants (Antiepileptic Drugs)IBA
12/2016 - 11/2006
2Formaldehyde (Formol)FDA Link
05/2011 - 10/2009
1InflammasomesIBA
04/2022
1Opioid Analgesics (Opioids)IBA
04/2022
1N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA
04/2022
1Anti-Inflammatory Agents (Anti-Inflammatories)IBA
04/2022
1Analgesics (Analgesic Drugs)IBA
04/2022
1Levamisole (Decaris)FDA Link
01/2022
1Sodium ChlorideFDA LinkGeneric
12/2021
1Hypertonic Saline SolutionIBA
12/2021
1Benzene (Benzole)IBA
12/2016
1Dopamine (Intropin)FDA LinkGeneric
10/2015
1Neurotransmitter Agents (Neurotransmitter)IBA
10/2015
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2015
1lorglumideIBA
05/2011
1Cholecystokinin Receptors (Cholecystokinin Receptor)IBA
05/2011
1Cholecystokinin (Pancreozymin)IBA
05/2011
1Lidocaine (Xylocaine)FDA LinkGeneric
05/2011
1YM 022IBA
05/2011
1Dynorphins (Dynorphin)IBA
05/2011
1Ethanol (Ethyl Alcohol)IBA
01/2011
1NociceptinIBA
10/2009
1EnkephalinsIBA
10/2009
1Leucine-2-Alanine Enkephalin (Enkephalin, Leucine 2 Alanine)IBA
10/2009
1(trans)-Isomer 3,4- Dichloro- N- methyl- N- (2- (1- pyrrolidinyl)- cyclohexyl)- benzeneacetamideIBA
10/2009
1MelatoninIBA
04/2009
1Hormones (Hormone)IBA
04/2009
1Free RadicalsIBA
04/2009
1Melatonin Receptors (Melatonin Receptor)IBA
04/2009
1asimadolineIBA
11/2007
1kappa Opioid Receptors (kappa Opioid Receptor)IBA
11/2007
1Messenger RNA (mRNA)IBA
11/2007
1ICI 204448IBA
11/2007
1Naloxone (Narcan)FDA LinkGeneric
11/2007
1Ion Channels (Ion Channel)IBA
11/2006
1Glycine (Aminoacetic Acid)FDA LinkGeneric
11/2006
1gamma-Aminobutyric Acid (GABA)IBA
11/2006
1Anti-Anxiety Agents (Anxiolytics)IBA
11/2006
1NicotineFDA Link
11/2006
1Pharmaceutical PreparationsIBA
10/2003

Therapy/Procedure

1Analgesia
04/2022
1Ligation
11/2007